227 related articles for article (PubMed ID: 7937920)
1. A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea.
Sharma PM; Bowman M; Yu BF; Sukumar S
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9931-5. PubMed ID: 7937920
[TBL] [Abstract][Full Text] [Related]
2. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
3. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
4. Eel WT1 sequence and expression in spontaneous nephroblastomas in Japanese eel.
Nakatsuru Y; Minami K; Yoshikawa A; Zhu J; Oda H; Masahito P; Okamoto N; Nakamura Y; Ishikawa T
Gene; 2000 Mar; 245(2):245-51. PubMed ID: 10717475
[TBL] [Abstract][Full Text] [Related]
5. Paired box gene expression in Wilms' tumor.
Tagge EP; Hanson P; Re GG; Othersen HB; Smith CD; Garvin AJ
J Pediatr Surg; 1994 Feb; 29(2):134-41. PubMed ID: 7909843
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
8. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds.
Ohgaki H; Hard GC; Hirota N; Maekawa A; Takahashi M; Kleihues P
Cancer Res; 1992 May; 52(10):2995-8. PubMed ID: 1316233
[TBL] [Abstract][Full Text] [Related]
9. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
10. RNA editing in the Wilms' tumor susceptibility gene, WT1.
Sharma PM; Bowman M; Madden SL; Rauscher FJ; Sukumar S
Genes Dev; 1994 Mar; 8(6):720-31. PubMed ID: 7926762
[TBL] [Abstract][Full Text] [Related]
11. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
12. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
Gerald WL; Gramling TS; Sens DA; Garvin AJ
Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
[TBL] [Abstract][Full Text] [Related]
13. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
[TBL] [Abstract][Full Text] [Related]
15. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.
Hu Q; Gao F; Tian W; Ruteshouser EC; Wang Y; Lazar A; Stewart J; Strong LC; Behringer RR; Huff V
J Clin Invest; 2011 Jan; 121(1):174-83. PubMed ID: 21123950
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
Baird PN; Pritchard J; Cowell JK
Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
[TBL] [Abstract][Full Text] [Related]
17. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
19. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
20. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
